Hanmi Pharm CEO Gwan-Sun Lee, "We’ll promptly resume clinical trials of drug postpone in manufacturing"
Hanmi Pharm(CEO Gwan-Sun Lee) has been the Korea’s center of attention for the past 2 years. Hanmi Pharm, which has received the praise as a company to nurture the country’s future growth through a series of new drug license agreements, has experienced huge pains, such as delay of notice and issu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
